SACRAMENTO, Calif., Sept. 11, 2017 -- IDdriven, Inc., (OTC:IDDR), an innovative provider of premises and cloud-based Identity and Access Management ("IAM") solutions is providing a further update on the progress into the medical market.
Last week’s signing of a contract with Lifespan Health System to onboard Lifespan’s 19,000 employees and contractors on the IDdriven software, is IDdriven’s first in the medical market. Revenue for this contract is expected to begin right at the start of Q4, and will be a monthly revenue stream for the duration of the agreement.
According to the American Hospital Organization, there are over 6000 hospitals in the US, with more than 3000 being part of a system (some form of common ownership). All have a common goal with respect to making sure that data access is protected, controlled and audited on a regular basis.
As a result, IDdriven currently sees growing interest among large and smaller hospital systems who are all working on getting better control over who is allowed access to what data. IDdriven is in active discussions in this market.
Arend Verweij, CEO of IDdriven, Inc. stated, “We have designed our software so the implementation process can go quickly and smoothly. This is a great benefit as it will allow for creating reports of the overall access status of the organization’s data without having to wait for months of implementation.”
About IDdriven
With its next-generation IDaaS program of the same name, IDdriven, Inc. is at the forefront of the new breed of Identity Management and Access Governance solutions. The company is currently researching and developing a solution for enterprises aimed at helping enterprises utilizing the benefits of consortium based blockchain and their frameworks. Taking the complexity and upfront costs out of implementation, IDdriven automates access security for vulnerable company assets by seamlessly integrating with the solutions from Microsoft, and other cloud providers like Amazon. Founded in 2013, IDdriven is headquartered in Sacramento, California. To learn more, visit: www.IDdriven.com.
Forward-Looking Statement Disclosure
This news release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond IDdriven’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) commercialization of our software programs, (ii) development and protection of our intellectual property, (iii) industry competition, (iv) we may need to raise capital to meet business requirements. More detailed information about IDdriven and the risk factors that may affect the realization of forward-looking statements is contained in our filings with the Securities and Exchange Commission which are available on our website and at www.sec.gov. IDdriven assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Company Contact
E: [email protected]
T: 415.226.7773


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 



